Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth C Nowak

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapyMarianne A Mihalyo, Amy D H Doody, Jeremy P McAleer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cellsDavid C Gondek, Victor Devries, Elizabeth C Nowak, et al.
Journal for Immunotherapy of Cancer|June 3, 2026
Systemic pre-conditioning favors effector over exhausted CD8 T-cell subsets following Sup2-IL33 armored CAR T-cell therapyShannon L Ferry, Leena Abdullah, Akshaya Balasubramanian, et al.
The Journal of Experimental Medicine|September 26, 2012
Tryptophan hydroxylase-1 regulates immune tolerance and inflammationElizabeth C Nowak, Victor C de Vries, Anna Wasiuk, et al.
The Journal of Experimental Medicine|July 15, 2009
IL-9 as a mediator of Th17-driven inflammatory diseaseElizabeth C Nowak, Casey T Weaver, Henrietta Turner, et al.
Cell Reports|February 20, 2026
Heterogeneity and plasticity of the naive CD4<sup>+</sup> T cell compartmentAlia Sajani, Evelien Schaafsma, Walburga Croteau, et al.
Research Square|January 27, 2025
Heterogeneity and plasticity of the naïve CD4<sup>+</sup> T cell compartmentAlia Sajani, Evelien Schaafsma, Walburga Croteau, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2014
Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunityLi Wang, Isabelle Le Mercier, Juan Putra, et al.
Immunological Reviews|March 5, 2017
Immunoregulatory functions of VISTAElizabeth C Nowak, J Louise Lines, Frederick S Varn, et al.
Cancer Immunology Research|October 19, 2022
VISTA Targeting of T-cell Quiescence and Myeloid Suppression Overcomes Adaptive ResistanceEvelien Schaafsma, Walburga Croteau, Mohamed ElTanbouly, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapyMarianne A Mihalyo, Amy D H Doody, Jeremy P McAleer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cellsDavid C Gondek, Victor Devries, Elizabeth C Nowak, et al.
Journal for Immunotherapy of Cancer|June 3, 2026
Systemic pre-conditioning favors effector over exhausted CD8 T-cell subsets following Sup2-IL33 armored CAR T-cell therapyShannon L Ferry, Leena Abdullah, Akshaya Balasubramanian, et al.
The Journal of Experimental Medicine|September 26, 2012
Tryptophan hydroxylase-1 regulates immune tolerance and inflammationElizabeth C Nowak, Victor C de Vries, Anna Wasiuk, et al.
The Journal of Experimental Medicine|July 15, 2009
IL-9 as a mediator of Th17-driven inflammatory diseaseElizabeth C Nowak, Casey T Weaver, Henrietta Turner, et al.
Cell Reports|February 20, 2026
Heterogeneity and plasticity of the naive CD4<sup>+</sup> T cell compartmentAlia Sajani, Evelien Schaafsma, Walburga Croteau, et al.
Research Square|January 27, 2025
Heterogeneity and plasticity of the naïve CD4<sup>+</sup> T cell compartmentAlia Sajani, Evelien Schaafsma, Walburga Croteau, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2014
Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunityLi Wang, Isabelle Le Mercier, Juan Putra, et al.
Immunological Reviews|March 5, 2017
Immunoregulatory functions of VISTAElizabeth C Nowak, J Louise Lines, Frederick S Varn, et al.
Cancer Immunology Research|October 19, 2022
VISTA Targeting of T-cell Quiescence and Myeloid Suppression Overcomes Adaptive ResistanceEvelien Schaafsma, Walburga Croteau, Mohamed ElTanbouly, et al.
Pageof 3